{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T04:24:00Z","timestamp":1793075040616,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T00:00:00Z","timestamp":1582502400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T00:00:00Z","timestamp":1582502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Research Pilot Project Award (University of Rochester Department of Obstetrics and Gynecology) and Drug Development Award"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Forchlorfenuron (FCF) is a synthetic plant cytokinin widely used in agriculture to promote fruit size, that paradoxically inhibits proliferation, migration, and invasion in human cancer cell lines. FCF has also been shown to affect HIF-1\u03b1 and HER2, which are both known to play a crucial role in cancer cell survival. In this study, we have developed potent FCF analogs through structural modification of FCF, coined UR214-1, UR214-7, and UR214-9. Compared to parental FCF, these analogs are more effective in decreasing viability and proliferation in both ovarian and endometrial cancer cell lines. These FCF analogs also suppress HER2 expression at a concentration lower than that of FCF. In addition, we found that treatment with either FCF or its analogs decreases the expression of human epididymis protein 4 (HE4), which is commonly upregulated in ovarian and endometrial cancers. Given the association between cancer behavior and HE4 production in gynecologic cancers, our findings may provide insight useful in the development of new treatment strategies for gynecologic cancers.<\/jats:p>","DOI":"10.1038\/s41598-020-59824-4","type":"journal-article","created":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T11:07:31Z","timestamp":1582542451000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Development of Potent Forchlorfenuron Analogs and Their Cytotoxic Effect in Cancer Cell Lines"],"prefix":"10.1038","volume":"10","author":[{"given":"Kyu Kwang","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negar","family":"Khazan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1415-3334","authenticated-orcid":false,"given":"Arif","family":"Kodza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niloy A.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umayal","family":"Sivagnanalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Towner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Itamochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard G.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,24]]},"reference":[{"key":"59824_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer Statistics, 2017. CA Cancer J. Clin. 67, 7\u201330, https:\/\/doi.org\/10.3322\/caac.21387 (2017).","journal-title":"CA Cancer J. Clin."},{"key":"59824_CR2","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.2174\/0929867323666160411142532","volume":"23","author":"L Garuti","year":"2016","unstructured":"Garuti, L., Roberti, M., Bottegoni, G. & Ferraro, M. Diaryl Urea: A Privileged Structure in Anticancer Agents. Curr. Med. Chem. 23, 1528\u20131548, https:\/\/doi.org\/10.2174\/0929867323666160411142532 (2016).","journal-title":"Curr. Med. Chem."},{"key":"59824_CR3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4103\/1735-5362.220971","volume":"13","author":"S Sadeghian-Rizi","year":"2018","unstructured":"Sadeghian-Rizi, S. et al. Synthesis and characterization of some novel diaryl urea derivatives bearing quinoxalindione moiety. Res. Pharm. Sci. 13, 82\u201392, https:\/\/doi.org\/10.4103\/1735-5362.220971 (2018).","journal-title":"Res. Pharm. Sci."},{"key":"59824_CR4","doi-asserted-by":"publisher","first-page":"6944","DOI":"10.18632\/oncotarget.27341","volume":"10","author":"W Blum","year":"2019","unstructured":"Blum, W. et al. The phytohormone forchlorfenuron decreases viability and proliferation of malignant mesothelioma cells in vitro and in vivo. Oncotarget 10, 6944\u20136956, https:\/\/doi.org\/10.18632\/oncotarget.27341 (2019).","journal-title":"Oncotarget"},{"key":"59824_CR5","doi-asserted-by":"publisher","first-page":"61587","DOI":"10.18632\/oncotarget.11402","volume":"7","author":"N Zhang","year":"2016","unstructured":"Zhang, N. et al. The requirement of SEPT2 and SEPT7 for migration and invasion in human breast cancer via MEK\/ERK activation. Oncotarget 7, 61587\u201361600, https:\/\/doi.org\/10.18632\/oncotarget.11402 (2016).","journal-title":"Oncotarget"},{"key":"59824_CR6","doi-asserted-by":"publisher","first-page":"e73179","DOI":"10.1371\/journal.pone.0073179","volume":"8","author":"D Vardi-Oknin","year":"2013","unstructured":"Vardi-Oknin, D., Golan, M. & Mabjeesh, N. J. Forchlorfenuron disrupts SEPT9_i1 filaments and inhibits HIF-1. Plos One 8, e73179, https:\/\/doi.org\/10.1371\/journal.pone.0073179 (2013).","journal-title":"Plos One"},{"key":"59824_CR7","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1042\/BCJ20160203","volume":"473","author":"EA Marcus","year":"2016","unstructured":"Marcus, E. A. et al. Septin oligomerization regulates persistent expression of ErbB2\/HER2 in gastric cancer cells. Biochem. J. 473, 1703\u20131718, https:\/\/doi.org\/10.1042\/BCJ20160203 (2016).","journal-title":"Biochem. J."},{"key":"59824_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3389\/fonc.2018.00124","volume":"8","author":"NE James","year":"2018","unstructured":"James, N. E., Chichester, C. & Ribeiro, J. R. Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer. Front. Oncol. 8, 124, https:\/\/doi.org\/10.3389\/fonc.2018.00124 (2018).","journal-title":"Front. Oncol."},{"key":"59824_CR9","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.ygyno.2007.10.017","volume":"108","author":"RG Moore","year":"2008","unstructured":"Moore, R. G. et al. The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass. Gynecol. Oncol. 108, 402\u2013408, https:\/\/doi.org\/10.1016\/j.ygyno.2007.10.017 (2008).","journal-title":"Gynecol. Oncol."},{"key":"59824_CR10","doi-asserted-by":"publisher","first-page":"351 e351","DOI":"10.1016\/j.ajog.2011.12.029","volume":"206","author":"RG Moore","year":"2012","unstructured":"Moore, R. G. et al. Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders. Am. J. Obstet. Gynecol. 206, 351 e351\u2013358, https:\/\/doi.org\/10.1016\/j.ajog.2011.12.029 (2012).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"59824_CR11","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1083\/jcb.201405050","volume":"207","author":"L Dolat","year":"2014","unstructured":"Dolat, L. et al. Septins promote stress fiber-mediated maturation of focal adhesions and renal epithelial motility. J. Cell Biol. 207, 225\u2013235, https:\/\/doi.org\/10.1083\/jcb.201405050 (2014).","journal-title":"J. Cell Biol."},{"key":"59824_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1515\/hsz-2012-0258","volume":"394","author":"Y Mizutani","year":"2013","unstructured":"Mizutani, Y. et al. Possible role of a septin, SEPT1, in spreading in squamous cell carcinoma DJM-1 cells. Biol. Chem. 394, 281\u2013290, https:\/\/doi.org\/10.1515\/hsz-2012-0258 (2013).","journal-title":"Biol. Chem."},{"key":"59824_CR13","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.3892\/or.2014.3055","volume":"31","author":"H Jiang","year":"2014","unstructured":"Jiang, H. et al. MicroRNA-127-3p promotes glioblastoma cell migration and invasion by targeting the tumor-suppressor gene SEPT7. Oncol. Rep. 31, 2261\u20132269, https:\/\/doi.org\/10.3892\/or.2014.3055 (2014).","journal-title":"Oncol. Rep."},{"key":"59824_CR14","doi-asserted-by":"publisher","first-page":"36063","DOI":"10.18632\/oncotarget.5373","volume":"6","author":"L Froidevaux-Klipfel","year":"2015","unstructured":"Froidevaux-Klipfel, L. et al. Septin cooperation with tubulin polyglutamylation contributes to cancer cell adaptation to taxanes. Oncotarget 6, 36063\u201336080, https:\/\/doi.org\/10.18632\/oncotarget.5373 (2015).","journal-title":"Oncotarget"},{"key":"59824_CR15","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.cellsig.2008.11.007","volume":"21","author":"ME Gonzalez","year":"2009","unstructured":"Gonzalez, M. E., Makarova, O., Peterson, E. A., Privette, L. M. & Petty, E. M. Up-regulation of SEPT9_v1 stabilizes c-Jun-N-terminal kinase and contributes to its pro-proliferative activity in mammary epithelial cells. Cell Signal. 21, 477\u2013487, https:\/\/doi.org\/10.1016\/j.cellsig.2008.11.007 (2009).","journal-title":"Cell Signal."},{"key":"59824_CR16","doi-asserted-by":"publisher","first-page":"e96390","DOI":"10.1371\/journal.pone.0096390","volume":"9","author":"D Angelis","year":"2014","unstructured":"Angelis, D., Karasmanis, E. P., Bai, X. & Spiliotis, E. T. In silico docking of forchlorfenuron (FCF) to septins suggests that FCF interferes with GTP binding. Plos One 9, e96390, https:\/\/doi.org\/10.1371\/journal.pone.0096390 (2014).","journal-title":"Plos One"},{"key":"59824_CR17","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1016\/j.celrep.2015.11.052","volume":"13","author":"F Calvo","year":"2015","unstructured":"Calvo, F. et al. Cdc42EP3\/BORG2 and Septin Network Enables Mechano-transduction and the Emergence of Cancer-Associated Fibroblasts. Cell Rep. 13, 2699\u20132714, https:\/\/doi.org\/10.1016\/j.celrep.2015.11.052 (2015).","journal-title":"Cell Rep."},{"key":"59824_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/srep03574","volume":"4","author":"RG Moore","year":"2014","unstructured":"Moore, R. G. et al. HE4 (WFDC2) gene overexpression promotes ovarian tumor growth. Sci. Rep. 4, 3574, https:\/\/doi.org\/10.1038\/srep03574 (2014).","journal-title":"Sci. Rep."},{"key":"59824_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/srep14296","volume":"5","author":"KK Kim","year":"2015","unstructured":"Kim, K. K. et al. Tetrathiomolybdate inhibits mitochondrial complex IV and mediates degradation of hypoxia-inducible factor-1alpha in cancer cells. Sci. Rep. 5, 14296, https:\/\/doi.org\/10.1038\/srep14296 (2015).","journal-title":"Sci. Rep."},{"key":"59824_CR20","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/nbt1210-1248","volume":"28","author":"M Uhlen","year":"2010","unstructured":"Uhlen, M. et al. Towards a knowledge-based Human Protein Atlas. Nat. Biotechnol. 28, 1248\u20131250, https:\/\/doi.org\/10.1038\/nbt1210-1248 (2010).","journal-title":"Nat. Biotechnol."},{"key":"59824_CR21","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1242\/jcs.162206","volume":"128","author":"K Diesenberg","year":"2015","unstructured":"Diesenberg, K., Beerbaum, M., Fink, U., Schmieder, P. & Krauss, M. SEPT9 negatively regulates ubiquitin-dependent downregulation of EGFR. J. Cell Sci. 128, 397\u2013407, https:\/\/doi.org\/10.1242\/jcs.162206 (2015).","journal-title":"J. Cell Sci."},{"key":"59824_CR22","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3389\/fcell.2016.00122","volume":"4","author":"D Angelis","year":"2016","unstructured":"Angelis, D. & Spiliotis, E. T. Septin Mutations in Human Cancers. Front. Cell Dev. Biol. 4, 122, https:\/\/doi.org\/10.3389\/fcell.2016.00122 (2016).","journal-title":"Front. Cell Dev. Biol."},{"key":"59824_CR23","doi-asserted-by":"publisher","first-page":"11142","DOI":"10.1074\/jbc.M808348200","volume":"284","author":"S Amir","year":"2009","unstructured":"Amir, S., Wang, R., Simons, J. W. & Mabjeesh, N. J. SEPT9_v1 up-regulates hypoxia-inducible factor 1 by preventing its RACK1-mediated degradation. J. Biol. Chem. 284, 11142\u201311151, https:\/\/doi.org\/10.1074\/jbc.M808348200 (2009).","journal-title":"J. Biol. Chem."},{"key":"59824_CR24","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ygyno.2008.04.002","volume":"110","author":"RG Moore","year":"2008","unstructured":"Moore, R. G. et al. Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus. Gynecol. Oncol. 110, 196\u2013201, https:\/\/doi.org\/10.1016\/j.ygyno.2008.04.002 (2008).","journal-title":"Gynecol. Oncol."},{"key":"59824_CR25","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/tpj.12147","volume":"74","author":"T Yamazaki","year":"2013","unstructured":"Yamazaki, T. et al. Localization and evolution of septins in algae. Plant. J. 74, 605\u2013614, https:\/\/doi.org\/10.1111\/tpj.12147 (2013).","journal-title":"Plant. J."},{"key":"59824_CR26","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.biochi.2010.05.006","volume":"92","author":"D Kopecny","year":"2010","unstructured":"Kopecny, D. et al. Phenyl- and benzylurea cytokinins as competitive inhibitors of cytokinin oxidase\/dehydrogenase: a structural study. Biochim. 92, 1052\u20131062, https:\/\/doi.org\/10.1016\/j.biochi.2010.05.006 (2010).","journal-title":"Biochim."},{"key":"59824_CR27","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1128\/EC.00191-14","volume":"13","author":"LR Heasley","year":"2014","unstructured":"Heasley, L. R., Garcia, G. III & McMurray, M. A. Off-target effects of the septin drug forchlorfenuron on nonplant eukaryotes. Eukaryot. Cell 13, 1411\u20131420, https:\/\/doi.org\/10.1128\/EC.00191-14 (2014).","journal-title":"Eukaryot. Cell"},{"key":"59824_CR28","doi-asserted-by":"publisher","first-page":"29563","DOI":"10.1074\/jbc.M804962200","volume":"283","author":"Q Hu","year":"2008","unstructured":"Hu, Q., Nelson, W. J. & Spiliotis, E. T. Forchlorfenuron alters mammalian septin assembly, organization, and dynamics. J. Biol. Chem. 283, 29563\u201329571, https:\/\/doi.org\/10.1074\/jbc.M804962200 (2008).","journal-title":"J. Biol. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59824-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59824-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59824-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T07:40:39Z","timestamp":1670312439000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59824-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,24]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["59824"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-59824-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,24]]},"assertion":[{"value":"29 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.K.K., R.K.S., R.T. and R.G.M. are listed on a patent application relating to this study. Other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3241"}}